SA Asks: What's the Most Attractive Weight-loss Stock Right Now?

Seeking AlphaFeb 3 12:30 ET

Metsera Sees Stock Rally 54% Following $275M IPO

Seeking AlphaJan 31 13:08 ET

Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference

GlobeNewswireJan 29 07:30 ET

Novo Nordisk's Ozempic Gets FDA Approval for Kidney Disease

Seeking AlphaJan 28 15:15 ET

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsJan 28 08:31 ET · Ratings

Allurion Stock Soars 70% on Weight-loss Therapy Update

Seeking AlphaJan 23 18:07 ET